BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32311005)

  • 1. MASTL promotes cell contractility and motility through kinase-independent signaling.
    Taskinen ME; Närvä E; Conway JRW; Hinojosa LS; Lilla S; Mai A; De Franceschi N; Elo LL; Grosse R; Zanivan S; Norman JC; Ivaska J
    J Cell Biol; 2020 Jun; 219(6):. PubMed ID: 32311005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinase-Independent Functions of MASTL in Cancer: A New Perspective on MASTL Targeting.
    Conway JRW; Närvä E; Taskinen ME; Ivaska J
    Cells; 2020 Jul; 9(7):. PubMed ID: 32640605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardin-related transcription factor A (MRTF-A) activity-dependent cell adhesion is correlated to focal adhesion kinase (FAK) activity.
    Kishi T; Mayanagi T; Iwabuchi S; Akasaka T; Sobue K
    Oncotarget; 2016 Nov; 7(44):72113-72130. PubMed ID: 27708220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4.
    Häbig K; Gellhaar S; Heim B; Djuric V; Giesert F; Wurst W; Walter C; Hentrich T; Riess O; Bonin M
    Biochim Biophys Acta; 2013 Dec; 1832(12):2352-67. PubMed ID: 24075941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear RhoA signaling regulates MRTF-dependent SMC-specific transcription.
    Staus DP; Weise-Cross L; Mangum KD; Medlin MD; Mangiante L; Taylor JM; Mack CP
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H379-90. PubMed ID: 24906914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MASTL overexpression promotes chromosome instability and metastasis in breast cancer.
    Rogers S; McCloy RA; Parker BL; Gallego-Ortega D; Law AMK; Chin VT; Conway JRW; Fey D; Millar EKA; O'Toole S; Deng N; Swarbrick A; Chastain PD; Cesare AJ; Timpson P; Caldon CE; Croucher DR; James DE; Watkins DN; Burgess A
    Oncogene; 2018 Aug; 37(33):4518-4533. PubMed ID: 29743597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.
    Shi Z; Ren M; Rockey DC
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G504-G517. PubMed ID: 31928221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of Microtubule Associated Serine/threonine Kinase Like Expression Inhibits Gastric Cancer Cell Growth and Induces Apoptosis by Activation of ERK1/2 and Inactivation of NF-κB Signaling.
    An CX; Xie SP; Li HL; Hu YH; Niu R; Zhang LJ; Jiang Y; Li Q; Zhou YN
    Curr Med Sci; 2021 Feb; 41(1):108-117. PubMed ID: 33582914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A β2-Integrin/MRTF-A/SRF Pathway Regulates Dendritic Cell Gene Expression, Adhesion, and Traction Force Generation.
    Guenther C; Faisal I; Uotila LM; Asens ML; Harjunpää H; Savinko T; Öhman T; Yao S; Moser M; Morris SW; Tojkander S; Fagerholm SC
    Front Immunol; 2019; 10():1138. PubMed ID: 31191527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MASTL is the human orthologue of Greatwall kinase that facilitates mitotic entry, anaphase and cytokinesis.
    Voets E; Wolthuis RM
    Cell Cycle; 2010 Sep; 9(17):3591-601. PubMed ID: 20818157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytopenia-associated mutations in Ser/Thr kinase MASTL deregulate actin cytoskeletal dynamics in platelets.
    Hurtado B; Trakala M; Ximénez-Embún P; El Bakkali A; Partida D; Sanz-Castillo B; Álvarez-Fernández M; Maroto M; Sánchez-Martínez R; Martínez L; Muñoz J; García de Frutos P; Malumbres M
    J Clin Invest; 2018 Dec; 128(12):5351-5367. PubMed ID: 30252678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polarity-regulating kinase partitioning-defective 1b (PAR1b) phosphorylates guanine nucleotide exchange factor H1 (GEF-H1) to regulate RhoA-dependent actin cytoskeletal reorganization.
    Yamahashi Y; Saito Y; Murata-Kamiya N; Hatakeyama M
    J Biol Chem; 2011 Dec; 286(52):44576-84. PubMed ID: 22072711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarity.
    Sandí MJ; Marshall CB; Balan M; Coyaud É; Zhou M; Monson DM; Ishiyama N; Chandrakumar AA; La Rose J; Couzens AL; Gingras AC; Raught B; Xu W; Ikura M; Morrison DK; Rottapel R
    Sci Signal; 2017 Oct; 10(503):. PubMed ID: 29089450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MASTL: A novel therapeutic target for Cancer Malignancy.
    Fatima I; Singh AB; Dhawan P
    Cancer Med; 2020 Sep; 9(17):6322-6329. PubMed ID: 32692487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitosis perturbation by MASTL depletion impairs the viability of thyroid tumor cells.
    Cetti E; Di Marco T; Mauro G; Mazzoni M; Lecis D; Minna E; Gioiosa L; Brich S; Pagliardini S; Borrello MG; Pruneri G; Anania MC; Greco A
    Cancer Lett; 2019 Feb; 442():362-372. PubMed ID: 30445205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vimentin intermediate filaments control actin stress fiber assembly through GEF-H1 and RhoA.
    Jiu Y; Peränen J; Schaible N; Cheng F; Eriksson JE; Krishnan R; Lappalainen P
    J Cell Sci; 2017 Mar; 130(5):892-902. PubMed ID: 28096473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of arginyltransferase 1 induces transcriptional activity of myocardin-related transcription factor A (MRTF-A) and promotes directional migration.
    Eisenach PA; Schikora F; Posern G
    J Biol Chem; 2014 Dec; 289(51):35376-87. PubMed ID: 25381249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct roles of nonmuscle myosin II isoforms in the regulation of MDA-MB-231 breast cancer cell spreading and migration.
    Betapudi V; Licate LS; Egelhoff TT
    Cancer Res; 2006 May; 66(9):4725-33. PubMed ID: 16651425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling.
    Uppada SB; Gowrikumar S; Ahmad R; Kumar B; Szeglin B; Chen X; Smith JJ; Batra SK; Singh AB; Dhawan P
    Mol Cancer; 2018 Aug; 17(1):111. PubMed ID: 30068336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F8 confers cisplatin resistance to ER+ breast cancer cells via transcriptionally activating MASTL.
    Tian J; Lin Y; Yu J
    Biomed Pharmacother; 2017 Aug; 92():919-926. PubMed ID: 28605876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.